Search alternatives:
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
0 decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
01 0 » 0 0 (Expand Search), 1 0 (Expand Search), 01 1 (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
0 decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
01 0 » 0 0 (Expand Search), 1 0 (Expand Search), 01 1 (Expand Search)
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses
Published 2025“…By compiling a global data set of 1,782 paired observations from 185 publications, we show that land use conversion from natural to managed ecosystems significantly reduced NNM by 7.5% (−11.5, −2.8%) and increased NN by 150% (86, 194%), indicating decreasing N availability while increasing potential N loss through denitrification and nitrate leaching. …”
-
91
Image_1_IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.TIF
Published 2021“…IL-17A and F, TNF, IL-6, IL-8, and IL-12p40 were not significantly downregulated in qPCR analysis of W12 total biopsies, only MMP3 and IL-23p19 were significantly decreased. RNA-seq analysis revealed 178 significantly differentially expressed genes between baseline and 12 weeks (FDR 0.1). …”
-
92
-
93
-
94
-
95
-
96
-
97
-
98
Top elevated (>1.30-fold and p value <0.1) and decreased (<1.30-fold and p value <0.1) proteins from serum exosomes of patients with Raynaud’s Phenomenon with positive ANA compared with serum exosomes from patients with Raynaud’s Phenomenon with negative ANA identified by aptamer proteomics.
Published 2022“…<p>Top elevated (>1.30-fold and p value <0.1) and decreased (<1.30-fold and p value <0.1) proteins from serum exosomes of patients with Raynaud’s Phenomenon with positive ANA compared with serum exosomes from patients with Raynaud’s Phenomenon with negative ANA identified by aptamer proteomics.…”
-
99
-
100